Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrustpilot Regulatory News (TRST)

Share Price Information for Trustpilot (TRST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    4.20 (1.68%)
Bid:
256.20
Ask:
256.80
Spread: 0.60 (0.234%)
Market Cap: £982.28m
TRST Live PriceLast checked at - London Stock Exchange

Intraday Trustpilot Share Chart

Trading Statement

13 Jul 2023 07:00

RNS Number : 9142F
Trustpilot Group PLC
13 July 2023
 

Trustpilot Group plc

13 July 2023

 

Trading update for the half-year ended 30 June 2023

 

Group revenue increased 18% with H1 adj. EBITDA of approximately $3m - upgrading profitability guidance for FY23

 

Trustpilot Group plc ("Trustpilot"), a leading global review platform, provides an update on trading for the six months ended 30 June 2023 ("H1'23").

 

US$

H1'23

H1'22

YoY actual

%

YoY constant currency %

Total revenue

$85m

$73m

+15

+18

ARR1

$180m

$149m

+21

+17

Total bookings2

$98m

$87m

+13

+16

 

H1'23 financial highlights

Trustpilot expects to report Group revenue of $85m (H1'22: $73m), up 18%3 at constant currency, with adj. EBITDA of approximately $3m (H1'22: $(5.4)m). We expect total annual recurring revenue (ARR) of $180m (H1'22: $149m), up 17%, with total bookings up 16% to $98m (H1'22: $87m). The last twelve months ("LTM") net dollar retention rate was 99% in the period (H1'22: 100%).

 

Regionally, bookings growth was 15% in the UK and 21% in Europe & RoW, a resilient performance against a challenging macroeconomic backdrop. In North America, bookings increased 11%, with an acceleration in Q2 aided by an encouraging improvement in our US net dollar retention rate, and continuing benefits from our refreshed go-to-market strategy in the region.

 

Our balance sheet remains strong and our net cash balance increased to $83m at the end of H1, reflecting positive free cash flow in the period, compared to $73.5m on 31 December 2022.

 

Update on appointment of new Chief Executive Officer

We are pleased with the progress being made in the search for a new Chief Executive Officer and look forward to updating the market in due course.

 

Outlook

We reiterate our expectation for FY'23 of mid-teens cc revenue growth. Due to resilient trading combined with improved operational efficiency, we now expect like-for-like full-year adj. EBITDA4 above the top end of the range of market expectations5 (excluding the effects of IFRS 15 - see note 6 below).

 

Notice of half-year results

Trustpilot is scheduled to report interim results for the six months ended 30 June 2023 on Tuesday 19 September 2023. On that day, a webcast and conference call for analysts and investors will take place at 09:00 BST. For registration and access to the webcast please visit https://investors.trustpilot.com.

 

 

Enquiries

Trustpilot

Derek Brown, Head of Investor Relations

Peter Holten Mühlmann, CEO

Hanno Damm, CFO

 

investor.relations@trustpilot.com

https://investors.trustpilot.com

 

Financial PR

Teneo

James Macey White

Ed Cropley

+44 20 7353 4200

 

About Trustpilot

Trustpilot was founded in 2007 with a vision to create an independent currency of trust. A digital platform that brings businesses and consumers together to foster trust and inspire collaboration. We are free to use, open to everybody and built on transparency.

 

Trustpilot hosts reviews to help consumers shop with confidence and deliver rich insights to help businesses improve the experience they offer. The more consumers use our platform and share their own opinions; the richer the insights we offer businesses; and the more opportunities they have to earn the trust of consumers, from all around the world.

 

Trustpilot has over 850 employees and is headquartered in Copenhagen, with operations in London, Edinburgh, New York, Denver, Melbourne, Berlin, Amsterdam, and Milan.

 

1 Annual Recurring Revenue = Monthly Recurring Revenue x 12

2 The annual contract value of contracts signed in a given period

3 All YoY growth rates are shown on a constant currency basis

4 Adjusted EBITDA is defined as earnings before interest, tax, depreciation and amortisation, adjusted to exclude share-based compensation and restructuring costs

5 The current analyst consensus range for adjusted EBITDA of $2.4m to 4.0m (with a mean of $2.9m), based on company-compiled consensus representing the aggregate forecasts of 8 analysts collated on 28 April 2023

6 As our business expands and becomes profitable, under IFRS 15 - "Revenue from Contracts with Customers" - the Group is required to assess the recoverability of the incremental costs of obtaining a contract. Incremental costs for the Group relate largely to sales commissions paid to employees on new business. The Group has performed an assessment of recoverability and where costs are recoverable the Group intends to capitalise these commissions in H1'23 and to amortise them over the customer's expected useful life.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGMNZFFGFZG
Date   Source Headline
30th Nov 20222:44 pmRNSTotal Voting Rights
3rd Nov 202212:20 pmRNSDirector Declaration
1st Nov 20227:00 amRNSTR-1 - Notification of major holdings
31st Oct 20223:03 pmRNSTotal Voting Rights
17th Oct 20224:30 pmRNSPDMR notification - grant of RSP award
4th Oct 20222:32 pmRNSDirector/PDMR Shareholding
30th Sep 20222:12 pmRNSTotal Voting Rights
27th Sep 20227:00 amRNSAppointment of Joint Corporate Broker
15th Sep 20227:09 amRNSDirectorate Change
14th Sep 20222:20 pmRNSDirector/PDMR Shareholding
13th Sep 20227:00 amRNSHalf-year Results
31st Aug 20222:03 pmRNSTotal Voting Rights
9th Aug 202210:31 amRNSTR-1 - Notification of major holdings
14th Jul 20227:00 amRNSTrading update for half-year ended 30 June 2022
1st Jul 20222:06 pmRNSBlock listing Interim Review
30th Jun 20222:00 pmRNSTotal Voting Rights
22nd Jun 20224:00 pmRNSTR-1 - Notification of major holdings
22nd Jun 20227:00 amRNSPDMR notification - grant of LTIP and RSP awards
16th Jun 20227:00 amRNSCapital Markets Day
31st May 20222:49 pmRNSTotal Voting Rights
25th May 20224:20 pmRNSResult of AGM
29th Apr 20222:35 pmRNSTotal Voting Rights
27th Apr 20224:28 pmRNSDirector/PDMR Shareholding
20th Apr 20225:51 pmRNSAnnual Financial Report
14th Apr 20224:41 pmRNSTR1 - Notification of major holdings
8th Apr 20227:00 amRNSPDMR notification - grant of LTIP awards
5th Apr 20225:33 pmRNSDirector/PDMR Shareholding
4th Apr 20226:22 pmRNSDirector/PDMR Shareholding
31st Mar 20222:00 pmRNSTotal Voting Rights
29th Mar 20228:29 amRNSTR1 - Notification of major holdings
24th Mar 20227:00 amRNSTR1 - Notification of major holdings
24th Mar 20227:00 amRNSBlock Listing Application
23rd Mar 20222:18 pmRNSDirector/PDMR Shareholding
22nd Mar 20227:00 amRNSResults for the year ended 31 December 2021 (FY21)
1st Mar 20227:00 amRNSTR1 - Notification of major holdings
28th Feb 202212:00 pmRNSTotal Voting Rights
11th Feb 20222:57 pmRNSTR1 - Notification of major holdings
31st Jan 20221:18 pmRNSTotal Voting Rights
31st Jan 202211:00 amRNSTR1 - Notification of major holdings
20th Jan 20223:40 pmRNSTR-1 - Notification of major holdings
12th Jan 20227:00 amRNSTrading update for the year to 31 December, 2021
4th Jan 20227:00 amRNSBlock listing Interim Review
31st Dec 20211:19 pmRNSTotal Voting Rights
30th Nov 20213:00 pmRNSTotal Voting Rights
26th Nov 202111:00 amRNSDirector/PDMR Shareholding
18th Nov 20213:30 pmRNSDirector/PDMR Shareholding
16th Nov 202111:00 amRNSPDMR notification - grant of RSP awards
11th Nov 20218:00 amRNSDirector Declaration
5th Nov 202112:30 pmRNSDirector/PDMR Shareholding
29th Oct 20212:55 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.